Clinical Trials Sponsored by Fresenius Medical Care Europe

Total 121 results

Fresenius Medical Care Korea

Completed

The Clinical Effects of Korean Adapted APD in Automated Peritoneal Dialysis Patients

Renal Insufficiency, Chronic

Korea, Republic of
Fresenius Medical Care Korea

Completed

Quality of Life and Depression in Dialysis Patients (QOLD)

Chronic Kidney Disease Stage 5

Korea, Republic of
Francisco Maduell
Fresenius Medical Care Europe

Completed

Optimizing Fluid Status

Hypotension During Dialysis

Spain
Fresenius Medical Care Deutschland GmbH

Not yet recruiting

Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis (SODIAH)

End Stage Renal Disease
Fresenius Medical Care Deutschland GmbH

Completed

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI (DIAMOND-2018)

Cardiovascular Diseases | Dyslipidemias | Hypercholesterolemia, Familial

Germany
Fresenius Medical Care North America

Completed

Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™

Chronic Kidney Diseases | Patient Requiring Heparin Free Dialysis Treatments

United States
Fresenius Medical Care Deutschland GmbH

Completed

Pilot Medical Evaluation of the T50 Test

Cardiovascular Diseases | Renal Failure | Vascular Calcification

Spain
Fresenius Medical Care Deutschland GmbH

Terminated

Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration (GENTLE-UF)

Acute Heart Failure | Volume Overload | Cardiac Decompensation

Sweden, Switzerland, Germany
Fresenius Medical Care Deutschland GmbH

Completed

HaemoDialysis Interventions to REduce Multi-Organ Dysfunction and Effect on Quality of Life Assessed by MRI Scanning (HD-REMODEL)

Cardiovascular Diseases | Renal Failure | Congenital Disorders

United Kingdom
Fresenius Medical Care Deutschland GmbH

Completed

PD-Improved Dialysis Efficiency With Adapted APD (PD-IDEA)

Chronic Renal Failure

Spain, Sweden, Finland, Czechia, Denmark, Malaysia
Fresenius Medical Care Deutschland GmbH

Completed

Initiative for Patient Outcomes in Dialysis - Peritoneal Dialysis (PD) (IPOD-PD Study) (IPOD-PD)

Chronic Renal Failure

Spain, Korea, Republic of, Denmark, Finland, Netherlands, Belgium, United Kingdom, Turkey, France, Italy, Estonia, Sweden, Czech Republic, Austria, Bosnia and Herzegovina, Brazil, Croatia, Cuba, Germany, Greece, India, Israel, Latvia, Lithuani... and more
Fresenius Medical Care Deutschland GmbH

Completed

The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis

Chronic Renal Failure

Spain, Poland
Fresenius Medical Care Deutschland GmbH

Completed

Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study) (ESPIRA)

Allergic Asthma

Austria
Fresenius Medical Care Deutschland GmbH

Completed

Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD (PDOne)

Chronic Kidney Failure

United Kingdom, Denmark, Sweden, France, Germany
Fresenius Medical Care Deutschland GmbH

Completed

Application of Citrate Dialysate in Chronic Haemodialysis

Chronic Renal Disease

Germany
Fresenius Medical Care North America

Completed

Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers

Hyperphosphatemia

United States
Fresenius Medical Care North America

Completed

Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers

Inflammation | End Stage Renal Disease

United States
Fresenius Medical Care North America

Completed

Fresenius Noninvasive Blood Pressure Validation (BPM2)

Blood Pressure

United States
Fresenius Medical Care Deutschland GmbH

Completed

Comparative Safety and Clinical Performance of Dialyzers Applied During Post-dilution Online Hemodiafiltration (eMPORA II)

Renal Failure | End Stage Renal Disease

Germany
Fresenius Medical Care Deutschland GmbH

Completed

Safety and Clinical Performance of a Dialyzer With a Modified Polysulfone Membrane (eMPORA)

Renal Failure | End Stage Renal Disease

Germany
Fresenius Medical Care North America

Completed

Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients (COS-002)

Chronic Kidney Disease

United States
Fresenius Medical Care Deutschland GmbH

Completed

Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter (LINET)

Hypercholesterolemia, Familial | LIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIA

Germany
Fresenius Medical Care Deutschland GmbH

Completed

Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules (OsvaRenNEW)

Chronic Kidney Disease | Hyperphosphatemia

Germany
Fresenius Medical Care North America

Terminated

A Safety Study of Pentoxifylline for the Treatment of Anemia

End Stage Renal Disease

United States
Fresenius Medical Care North America

Recruiting

SAfety of Regional Citrate Anticoagulation (SARCA Study) (SARCA)

Acute Kidney Injury | ESRD

United States
Fresenius Medical Care Deutschland GmbH

Terminated

Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy (COVID-thIRd)

COVID-19 | Chronic Kidney Diseases | Hemodialysis

Spain, Portugal
Fresenius Medical Care Deutschland GmbH

Terminated

PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure

Heart Failure | Acute Heart Failure

Germany, Sweden
Fresenius Medical Care North America

Completed

Clinical Study to Assess the Performance of the Dialyzer With Endexo™

Kidney Failure, Chronic

United States
Fresenius Medical Care North America

Completed

Acid-Base Composition With Use of hemoDialysates (ABChD)

End Stage Renal Disease

United States
Fresenius Medical Care North America

Completed

Phosphate Kinetic Modeling (PKM)

End Stage Renal Disease | Hyperphosphatemia

United States
Fresenius Medical Care North America

Unknown

Impact of Adherence to Anemia Management Policy on Repeat Hospitalization in End Stage Renal Disease (ESRD)

Mortality | Anemia

United States
Vifor Fresenius Medical Care Renal Pharma
Worldwide Clinical Trials; Fresenius Medical Care Deutschland GmbH

Terminated

Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial (ANEMEX)

Anemia | End Stage Renal Disease

United Kingdom
Vifor Fresenius Medical Care Renal Pharma

Recruiting

Avacostar - (PASS) (Avacostar)

ANCA-associated Vasculitis

United Kingdom, Germany
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Fresenius Medical Care North America
Amgen

Unknown

Care Transitions in Renal Disease Patients (CT)

Renal Disease

United States
Fresenius Medical Care North America
Abbott

Completed

Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients

Kidney Failure

United States
Vifor Fresenius Medical Care Renal Pharma

Completed

PA21 Safety and Efficacy in Adult Chinese Subjects

Hyperphosphatemia | Chronic Kidney Disease Requiring Chronic Dialysis

China
Vifor Fresenius Medical Care Renal Pharma

Terminated

A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia

Hyperphosphatemia

United States, Poland, Germany, Lithuania, France, Romania, Russian Federation
Fresenius Medical Care Deutschland GmbH
CERES GmbH

Recruiting

Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy (multiECCO2R)

Covid19 | Acute Kidney Injury | Acute Lung Injury | Hypercapnia

Germany
Fresenius Medical Care Deutschland GmbH
Alcedis GmbH

Recruiting

Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine (SEPIAR)

Autoimmune Diseases

Germany
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, Belgium, Croatia, Austria, Czech Republic, Germany, Lithuania, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
Ege University
Fresenius Medical Care North America

Completed

Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)

Hemodialysis | End-stage Renal Disease

Turkey
Ege University
Fresenius Medical Care North America

Completed

Comparison of Four and Eight Hours Dialysis Sessions in Thrice Weekly Hemodialysis

Hemodialysis | End-Stage Renal Disease

Turkey
Ege University
Fresenius Medical Care North America

Completed

Effects Of Volume Control Guided by Body Composition Monitor (BCM) on Blood Pressure and Cardiac Condition in Hemodialysis Patients

Left Ventricular Hypertrophy

Turkey
Randolph Quinn

Completed

Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment

Renal Dialysis

United States
Fresenius Medical Care Deutschland GmbH
Alcedis GmbH

Recruiting

Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients (Genius)

Renal Failure | End Stage Renal Disease | Acute Renal Failure

Germany
Xenios AG

Not yet recruiting

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients (PulseSE)

Extracorporeal Membrane Oxygenation | Cardiogenic Shock | ECLS | VA ECMO

Germany
Vifor Pharma
Fresenius Medical Care North America

Completed

A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Chronic Kidney Disease Requiring Chronic Dialysis

Latvia, United States, South Africa, Belgium, Croatia, Germany, Poland, Romania, Serbia, Ukraine, United Kingdom, Austria, Czech Republic, Lithuania, Russian Federation
Kantonsspital Aarau
Fresenius Medical Care Deutschland GmbH

Completed

Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser

Renal Failure Chronic Requiring Hemodialysis

Switzerland
Vanderbilt University
Fresenius Medical Care North America

Completed

Provision of Antioxidant Therapy in Hemodialysis (PATH) Study

End-stage Renal Disease

United States

Clinical Trials Sponsored by Fresenius Medical Care Europe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations